News Focus
News Focus
Followers 303
Posts 4680
Boards Moderated 0
Alias Born 11/26/2009

Re: None

Thursday, 08/11/2011 7:04:20 AM

Thursday, August 11, 2011 7:04:20 AM

Post# of 97241
SQNM - Sequenom announces European licensing agreement with LifeCodexx

Sequenom announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in Germany, Austria, Switzerland, and Liechtenstein, with the potential for additional launches in other countries. The completion of the agreement with LifeCodexx initiates Sequenom's first European commercial partnership in the field of non-invasive prenatal diagnostics. Under this initial five year licensing agreement, Sequenom has granted LifeCodexx licenses to key patent rights, including European Patent EP0994963B1 and pending application EP2183693A1, that enable the development and commercialization of a non-invasive aneuploidy test utilizing circulating cell free fetal DNA in maternal plasma. Per the agreement, LifeCodexx will make certain upfront and minimum annual royalty payments to Sequenom as well as royalties based on sales of testing services. :theflyonthewall.

Visit us at the $heff $tation

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today